Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A38221 | 11870378 | Hepatology | Risk factors of fibrosis in alcohol-induced liver disease. | 2002 | Details |
| A38226 | 11851839 | J Gastroenterol Hepatol | Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury. | 2001 | Details |
| A38231 | 11826411 | Hepatology | NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. | 2002 | Details |
| A38233 | 11825539 | Curr Gastroenterol Rep | Evolving pathophysiologic concepts in nonalcoholic steatohepatitis. | 2002 | Details |
| A38249 | 11766638 | Pathologe | [Alcoholic and nonalcoholic steatohepatitis. Histopathologic and pathogenetic considerations]. | 2001 | Details |
| A38270 | 11732005 | Hepatology | Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. | 2001 | Details |
| A38276 | 11713934 | Dig Dis Sci | Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. | 2001 | Details |
| A38292 | 11676329 | Indian J Gastroenterol | Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. | 2001 | Details |
| A38311 | 11584370 | Hepatology | High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. | 2001 | Details |
| A38320 | 11569700 | Am J Gastroenterol | Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. | 2001 | Details |
| A38334 | 11522755 | Gastroenterology | Nonalcoholic steatohepatitis. | 2001 | Details |
| A38336 | 11513189 | Am J Gastroenterol | Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. | 2001 | Details |
| A38338 | 11501194 | Clin Cornerstone | Fatty liver and nonalcoholic steatohepatitis. | 2001 | Details |
| A38342 | 11495032 | J Hepatol | Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. | 2001 | Details |
| A38357 | 11454190 | Liver | Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. | 2001 | Details |
| A38378 | 11395389 | Am J Pathol | Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice. | 2001 | Details |
| A38395 | 11349722 | Transplantation | Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation. | 2001 | Details |
| A38400 | 11338474 | Am J Clin Pathol | Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis. | 2000 | Details |
| A38412 | 11303298 | Liver Transpl | Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. | 2001 | Details |
| A38416 | 11296695 | Semin Liver Dis | Nonalcoholic steatohepatitis: definition and pathology. | 2001 | Details |
| A38417 | 11296694 | Semin Liver Dis | Etiopathogenesis of nonalcoholic steatohepatitis. | 2001 | Details |
| A38443 | 11229116 | J Assoc Physicians India | Nonalcoholic steatohepatitis: clinicopathological profile. | 2000 | Details |
| A38448 | 11215693 | Biol Blood Marrow Transplant | Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation. | 2001 | Details |
| A38466 | 11169153 | Pathol Int | Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. | 2001 | Details |
| A38502 | 11097727 | Curr Treat Options Gastroenterol | Non-Alcoholic Steatohepatitis (NASH). | 1999 | Details |
| A38563 | 10923919 | Hum Pathol | Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver. | 2000 | Details |
| A38606 | 10799085 | Can J Gastroenterol | Nonalcoholic steatohepatitis: an evolving diagnosis. | 2000 | Details |
| A38689 | 10573511 | Hepatology | Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. | 1999 | Details |
| A38701 | 10535879 | Gastroenterology | Insulin resistance-associated hepatic iron overload. | 1999 | Details |
| A38723 | 10488699 | J Hepatol | Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. | 1999 | Details |
| A38725 | 10484010 | Am J Gastroenterol | Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. | 1999 | Details |
| A38742 | 10422202 | Semin Liver Dis | Nonalcoholic steatohepatitis. | 1999 | Details |
| A38781 | 10201476 | Am J Gastroenterol | The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. | 1999 | Details |
| A38829 | 9845426 | Semin Diagn Pathol | Diagnosis and interpretation of steatosis and steatohepatitis. | 1998 | Details |
| A38955 | 9453491 | Gastroenterology | Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. | 1998 | Details |
| A38961 | 9436007 | Gastroenterologist | Nonalcoholic fatty liver (NASH syndrome). | 1997 | Details |
| A39043 | 9195388 | J Gastroenterol Hepatol | Review: nonalcoholic steatohepatitis. | 1997 | Details |
| A39063 | 9346733 | Liver Transpl Surg | Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation. | 1997 | Details |
| A39083 | 9005748 | Ann Intern Med | Nonalcoholic steatohepatitis. | 1997 | Details |
| A39104 | 8990367 | Transplantation | Recurrence of nonalcoholic steatohepatitis following liver transplantation. | 1996 | Details |
| A39169 | 8804378 | Med Clin North Am | Nonalcoholic steatohepatitis. | 1996 | Details |
| A39214 | 8675165 | Hepatology | Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. | 1996 | Details |
| A39508 | 7922096 | Br J Surg | Predictors of upper gastrointestinal bleeding in patients with schistosomal periportal fibrosis. | 1994 | Details |
| A39877 | 1958998 | Br J Surg | Oesophageal varices in a region of the Sudan endemic for Schistosoma mansoni. | 1991 | Details |
| A39887 | 1928571 | Am J Trop Med Hyg | Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni. | 1991 | Details |
| A39916 | 1875751 | Med Clin (Barc) | [Non alcoholic steatohepatitis. Mid-term clinical and histologic course in 10 patients]. | 1991 | Details |
| A40035 | 2381201 | J Surg Res | Percutaneous ablation of gallstones. | 1990 | Details |
| A40187 | 2656500 | Hum Pathol | Nonalcoholic steatohepatitis: a study of 49 patients. | 1989 | Details |
| A40297 | 2900363 | Lancet | Effect of antischistosomal chemotherapy on prevalence of Symmers' periportal fibrosis in Sudanese villages. | 1988 | Details |
| A40380 | 3124648 | Am J Trop Med Hyg | Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study. | 1988 | Details |
| A40900 | 6753683 | Ann Intern Med | Schistosome infections in humans: perspectives and recent findings. NIH conference. | 1982 | Details |
| A41046 | 7192497 | Am J Trop Med Hyg | Hepatic fibrosis in rabbits infected with Japanese and Philippine strains of Schistosoma japonicum. | 1980 | Details |
| A42201 | 35256849 | Diabetes Metab Syndr Obes | MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients. | 2022 | Details |
| A42202 | 35247475 | J Ethnopharmacol | The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease. | 2022 | Details |
| A42205 | 35244954 | Periodontol 2000 | Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis. | 2022 | Details |
| A42219 | 35183767 | Clin Gastroenterol Hepatol | Bridging the gap: Screening for non-alcoholic fatty liver disease in the primary care population. | 2022 | Details |
| A42225 | 35169957 | Dig Dis Sci | "Wet Heparin" and "Wet Saline" EUS-Guided Liver Biopsy Techniques Both Provide High Rates of Specimen Adequacy for Benign Parenchymal Liver Disease. | 2022 | Details |
| A42236 | 35127953 | J Diabetes Res | Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center. | 2022 | Details |
| A42241 | 35119029 | Medicine (Baltimore) | Nonalcoholic non-virus-related hepatocellular carcinoma arising from nonsteatotic liver: Clinical and pathological features. | 2022 | Details |
| A42245 | 35107306 | AJR Am J Roentgenol | Automated CNN-Based Analysis Versus Manual Analysis for MR Elastography in Nonalcoholic Fatty Liver Disease: Inter-method Agreement and Fibrosis Stage Discriminative Performance. | 2022 | Details |
| A42250 | 35096251 | J Clin Aesthet Dermatol | Utility and Limitations of Transient Elastography to Monitor Hepatic Steatosis, Hepatic Fibrosis, and Methotrexate-Associated Hepatic Disease in Psoriasis: A Systematic Review. | 2021 | Details |
| A42251 | 35093588 | Cell Mol Gastroenterol Hepatol | Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver. | 2022 | Details |
| A42256 | 35084517 | Eur Radiol | Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic? | 2022 | Details |
| A42271 | 35034629 | BMC Gastroenterol | Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis. | 2022 | Details |
| A42280 | 35011717 | Cells | Pathologic Proteolytic Processing of N-Cadherin as a Marker of Human Fibrotic Disease. | 2022 | Details |
| A42288 | 34966660 | J Clin Transl Hepatol | Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease. | 2021 | Details |
| A42294 | 34943578 | Diagnostics (Basel) | The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students. | 2021 | Details |
| A42297 | 34935193 | Fundam Clin Pharmacol | Hepatoprotective and therapeutic effects of resveratrol: A focus on anti-inflammatory and antioxidative activities. | 2022 | Details |
| A42307 | 34915035 | Gastrointest Endosc | EUS imaging for the diagnosis of nonalcoholic fatty liver disease. | 2021 | Details |
| A42318 | 34886776 | Curr Vasc Pharmacol | Cilofexor for the Treatment of Nonalcoholic Steatohepatitis | 2022 | Details |
| A42322 | 34871785 | Ann Hepatol | Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease. | 2021 | Details |
| A42323 | 34870213 | Radiol Artif Intell | Deep Learning Prediction of Voxel-Level Liver Stiffness in Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42325 | 34863028 | Liver Int | NAFLD vs ALD: The unresolved duel between the bad and the worst. | 2021 | Details |
| A42335 | 34840727 | Clin Liver Dis (Hoboken) | Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Nonalcoholic Fatty Liver Disease Fibrosis Than Men: Summary of the Findings of a Systematic Review and Meta-analysis. | 2021 | Details |
| A42347 | 34805236 | Front Med (Lausanne) | Editorial: Organ Fibrosis: Pathogenesis, Biomarkers and Therapeutic Targets. | 2021 | Details |
| A42349 | 34801249 | J Hepatol | Liquid biomarkers for fibrotic NASH - progress in a complex field. | 2021 | Details |
| A42354 | 34778594 | J Clin Transl Res | Tagging incidental finding of fatty liver on ultrasound: A novel intervention to improve early detection of liver fibrosis. | 2021 | Details |
| A42356 | 34774458 | Rev Gastroenterol Mex (Engl Ed) | Evaluation of fibrosis in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A42362 | 34764874 | Front Pharmacol | Carnitine Palmitoyltransferase System: A New Target for Anti-Inflammatory and Anticancer Therapy? | 2021 | Details |
| A42374 | 34741324 | Aliment Pharmacol Ther | Editorial: biomarkers for alcohol-related liver fibrosis-almost there? Authors' reply. | 2021 | Details |
| A42382 | 34724297 | Hepatol Res | Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease. | 2021 | Details |
| A42403 | 34630116 | Front Pharmacol | An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism. | 2021 | Details |
| A42432 | 34540892 | Front Mol Biosci | Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway. | 2021 | Details |
| A42440 | 34516292 | Annu Rev Pharmacol Toxicol | Synthetic Retinoids Beyond Cancer Therapy. | 2021 | Details |
| A42460 | 34476661 | Dig Dis Sci | Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B. | 2021 | Details |
| A42465 | 34461208 | J Hepatol | Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease - implications for the clinical utility of the EASL NIT guideline. | 2021 | Details |
| A42467 | 34458710 | Surg Open Sci | In vivo diffuse reflectance spectroscopic analysis of fatty liver with inflammation in mice. | 2021 | Details |
| A42488 | 34400107 | Dig Liver Dis | Development of machine learning model to detect fibrotic non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A42489 | 34399043 | Ultrasonography | Accuracy of the ultrasound attenuation coefficient for the evaluation of hepatic steatosis: a systematic review and meta-analysis of prospective studies. | 2021 | Details |
| A42491 | 34390271 | Semin Dial | The relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients. | 2021 | Details |
| A42492 | 34387552 | JMIR Med Inform | Current-Visit and Next-Visit Prediction for Fatty Liver Disease With a Large-Scale Dataset: Model Development and Performance Comparison. | 2021 | Details |
| A42501 | 34362095 | J Clin Med | A Model Incorporating Serum Alkaline Phosphatase for Prediction of Liver Fibrosis in Adults with Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42521 | 34278437 | Int J Mol Med | Role of the S100 protein family in liver disease (Review). | 2021 | Details |
| A42528 | 34239349 | Int J Biol Sci | Dual-specificity Phosphatase 9 protects against Cardiac Hypertrophy by targeting ASK1. | 2021 | Details |
| A42529 | 34239266 | World J Gastroenterol | Neuropilin-1: A feasible link between liver pathologies and COVID-19. | 2021 | Details |
| A42552 | 34173916 | Dig Dis Sci | Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults. | 2021 | Details |
| A42554 | 34170539 | Aliment Pharmacol Ther | Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply. | 2021 | Details |
| A42555 | 34170537 | Aliment Pharmacol Ther | Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-the role for non-invasive testing. | 2021 | Details |
| A42566 | 34153303 | Metabolism | Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis. | 2021 | Details |
| A42573 | 34134003 | Clin Nutr | Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |